Clinical trials using apelin and apelin inhibitors have not been reported on PubMed to date, but apelin receptor expression has been reported to correlate with prognosis in patients with gastric cancer who were treated with chemoradiotherapy [164]. This evidence concerns the gene APLN and gastric cancer.